Published on 28 Jan 2025 on Zacks · via Yahoo Finance
MRK's sNDA for Welireg in Rare Tumors Gets FDA's Priority Tag
The FDA accepts and grants priority review to Merck's sNDA for Welireg to treat advanced...
NASDAQ.BMRN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free